找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Haploidentical Stem Cell Transplantation; An Emerging Treatmen Taner Demirer Book 2017 Springer International Publishing AG 2017 CD34+.Dono

[复制链接]
查看: 34100|回复: 49
发表于 2025-3-21 17:41:25 | 显示全部楼层 |阅读模式
书目名称Haploidentical Stem Cell Transplantation
副标题An Emerging Treatmen
编辑Taner Demirer
视频video
概述Authors are worldwide experts in the field and provide international perspectives and expertise.A rapidly developing modality; this topic has not yet appeared in many books but mostly in journal artic
丛书名称Stem Cell Biology and Regenerative Medicine
图书封面Titlebook: Haploidentical Stem Cell Transplantation; An Emerging Treatmen Taner Demirer Book 2017 Springer International Publishing AG 2017 CD34+.Dono
描述.This book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books‘ chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover, .Haploidentical Stem Cell Transplantation. brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome.. .
出版日期Book 2017
关键词CD34+; Donor Selection; Graft Failure; Leukemia; Lymphoma
版次1
doihttps://doi.org/10.1007/978-3-319-65319-8
isbn_softcover978-3-319-87999-4
isbn_ebook978-3-319-65319-8Series ISSN 2196-8985 Series E-ISSN 2196-8993
issn_series 2196-8985
copyrightSpringer International Publishing AG 2017
The information of publication is updating

书目名称Haploidentical Stem Cell Transplantation影响因子(影响力)




书目名称Haploidentical Stem Cell Transplantation影响因子(影响力)学科排名




书目名称Haploidentical Stem Cell Transplantation网络公开度




书目名称Haploidentical Stem Cell Transplantation网络公开度学科排名




书目名称Haploidentical Stem Cell Transplantation被引频次




书目名称Haploidentical Stem Cell Transplantation被引频次学科排名




书目名称Haploidentical Stem Cell Transplantation年度引用




书目名称Haploidentical Stem Cell Transplantation年度引用学科排名




书目名称Haploidentical Stem Cell Transplantation读者反馈




书目名称Haploidentical Stem Cell Transplantation读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:17:55 | 显示全部楼层
Donor Selection and Cell Dose in Haploidentical SCT,easy way to control the bidirectional alloreactivity, a problem that once was a major hassle to the advance of this procedure. Currently haploidentical stem cell transplantation represents the default option for alternative donor selection for some of the largest transplant centers around the world.
发表于 2025-3-22 02:24:12 | 显示全部楼层
发表于 2025-3-22 05:44:41 | 显示全部楼层
Toxicity of Conditioning Regimens in Haploidentical SCT,antations and even, the drugs are the same for both transplantation types. The advances in the haploidentical HSCT is mostly the result of the usage of post transplantation cyclophosphamide (PT-CY) as GVHD prophylaxis. At first PT-CY was used only in haplo setting however, today many centers use PT-
发表于 2025-3-22 10:57:18 | 显示全部楼层
发表于 2025-3-22 16:42:54 | 显示全部楼层
发表于 2025-3-22 19:38:50 | 显示全部楼层
Graft Versus Leukemia (GvL), Graft Versus Lymphoma Effect in Haploidentic SCT, inability to measure GvL in any other way than by assessing the reduction in relapse incidence with versus without an allogeneic stem cell transplant. The strength of GvL is probably enhanced in haploidentical SCT as compared to SCT from other donors given the added alloreactivity due to the HLA mi
发表于 2025-3-23 01:02:57 | 显示全部楼层
发表于 2025-3-23 02:36:46 | 显示全部楼层
发表于 2025-3-23 08:21:48 | 显示全部楼层
Applications of Haploidentical SCT in Patients with Non-malignant Diseases,n patients with non-malignant diseases, who are lacking a HLA identical sibling or compatible unrelated donor. T-cell depletion by CD34+ cell selection resulted in relative high risk of graft failure with exception of SCIDs. Further refinement has been reported for selected depletion of α/β T-cells
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-3 16:03
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表